MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ZYME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Zymeworks (ZYME) Ownership - Who owns Zymeworks?

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.81B
P/E Ratio
N/A
Total Cash
364.73M
Projected Growth
N/A
Total Debt
17.04M
Revenue
81.26M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
4.96
Total Debt/Equity
N/A
Revenue/Share
1.08 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ZYME
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ZYME
A.I. Advisor
published General Information

General Information

a company for cancer & autoimmune treatment

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
108 Patriot Drive
Phone
+1 302 274-8744
Employees
277
Web
https://www.zymeworks.com